144 related articles for article (PubMed ID: 2123871)
1. The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant delta FEIX with intact fibrin.
Nesheim M; Fredenburgh JC; Larsen GR
J Biol Chem; 1990 Dec; 265(35):21541-8. PubMed ID: 2123871
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
Stewart RJ; Fredenburgh JC; Weitz JI
J Biol Chem; 1998 Jul; 273(29):18292-9. PubMed ID: 9660794
[TBL] [Abstract][Full Text] [Related]
3. Epsilon amino caproic acid inhibits streptokinase-plasminogen activator complex formation and substrate binding through kringle-dependent mechanisms.
Lin LF; Houng A; Reed GL
Biochemistry; 2000 Apr; 39(16):4740-5. PubMed ID: 10769130
[TBL] [Abstract][Full Text] [Related]
4. Kringle glycosylation in a modified human tissue plasminogen activator improves functional properties.
Berg DT; Burck PJ; Berg DH; Grinnell BW
Blood; 1993 Mar; 81(5):1312-22. PubMed ID: 8382971
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of monoclonal antibodies directed against fibrin binding domains of tissue-type plasminogen activator.
Wojta J; Beckmann R; Turcu L; Wagner OF; van Zonneveld AJ; Binder BR
J Biol Chem; 1989 May; 264(14):7957-61. PubMed ID: 2470738
[TBL] [Abstract][Full Text] [Related]
6. Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.
Novokhatny V; Medved L; Lijnen HR; Ingham K
J Biol Chem; 1995 Apr; 270(15):8680-5. PubMed ID: 7721771
[TBL] [Abstract][Full Text] [Related]
7. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
Bakker AH; Nieuwenbroek NM; Verheijen JH
Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
[TBL] [Abstract][Full Text] [Related]
8. Role of the kringle domain in plasminogen activation with staphylokinase.
Arai K; Madoiwa S; Mimuro J; Asakura S; Matsuda M; Sako T; Sakata Y
J Biochem; 1998 Jan; 123(1):71-7. PubMed ID: 9504411
[TBL] [Abstract][Full Text] [Related]
9. A battery of monoclonal antibodies that induce unique conformations to evolve cryptic but constitutive functions of plasminogen.
Madoiwa S; Arai K; Ueda Y; Ishizuka M; Mimuro J; Asakura S; Matsuda M; Sakata Y
J Biochem; 1997 Feb; 121(2):278-87. PubMed ID: 9089401
[TBL] [Abstract][Full Text] [Related]
10. On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid.
van Zonneveld AJ; Veerman H; Pannekoek H
J Biol Chem; 1986 Oct; 261(30):14214-8. PubMed ID: 3021732
[TBL] [Abstract][Full Text] [Related]
11. Interactions between the finger and kringle-2 domains of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
Kaneko M; Sakata Y; Matsuda M; Mimuro J
J Biochem; 1992 Feb; 111(2):244-8. PubMed ID: 1314812
[TBL] [Abstract][Full Text] [Related]
12. Interaction of plasminogen and fibrin in plasminogen activation.
Wu HL; Chang BI; Wu DH; Chang LC; Gong CC; Lou KL; Shi GY
J Biol Chem; 1990 Nov; 265(32):19658-64. PubMed ID: 2174048
[TBL] [Abstract][Full Text] [Related]
13. Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli.
Wilhelm OG; Jaskunas SR; Vlahos CJ; Bang NU
J Biol Chem; 1990 Aug; 265(24):14606-11. PubMed ID: 2117612
[TBL] [Abstract][Full Text] [Related]
14. Role of the strictly conserved tryptophan-25 residue in the stabilization of the structure and in the ligand binding properties of the kringle 2 domain of tissue-type plasminogen activator.
De Serrano VS; Castellino FJ
Biochemistry; 1994 Feb; 33(6):1340-4. PubMed ID: 8312251
[TBL] [Abstract][Full Text] [Related]
15. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
Rydzewski A; Castellino FJ
Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of fibrin binding and activation of plasminogen by staplabin through induction of a conformational change in plasminogen.
Takayasu R; Hasumi K; Shinohara C; Endo A
FEBS Lett; 1997 Nov; 418(1-2):58-62. PubMed ID: 9414095
[TBL] [Abstract][Full Text] [Related]
17. Tissue-type plasminogen activator and its substrate Glu-plasminogen share common binding sites in limited plasmin-digested fibrin.
de Vries C; Veerman H; Koornneef E; Pannekoek H
J Biol Chem; 1990 Aug; 265(23):13547-52. PubMed ID: 2143185
[TBL] [Abstract][Full Text] [Related]
18. Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin.
Bok RA; Mangel WF
Biochemistry; 1985 Jun; 24(13):3279-86. PubMed ID: 3161540
[TBL] [Abstract][Full Text] [Related]
19. Construction, expression, and purification of recombinant kringle 1 of human plasminogen and analysis of its interaction with omega-amino acids.
Menhart N; Sehl LC; Kelley RF; Castellino FJ
Biochemistry; 1991 Feb; 30(7):1948-57. PubMed ID: 1993205
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of the amidolytic activity of single chain tissue-type plasminogen activator by fibrinogen degradation products: possible fibrin binding sites on single chain tissue-type plasminogen activator molecule.
Urano T; Takada Y; Takada A
Biochim Biophys Acta; 1991 Apr; 1077(3):245-52. PubMed ID: 1903067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
